Does empagliflozin modulate leukocyte–endothelium interactions, oxidative stress, and inflammation in type 2 diabetes?

  1. Canet, F.
  2. Iannantuoni, F.
  3. de Marañon, A.M.
  4. Díaz-Pozo, P.
  5. López-Domènech, S.
  6. Vezza, T.
  7. Navarro, B.
  8. Solá, E.
  9. Falcón, R.
  10. Bañuls, C.
  11. Morillas, C.
  12. Rocha, M.
  13. Víctor, V.M.
Journal:
Antioxidants

ISSN: 2076-3921

Year of publication: 2021

Volume: 10

Issue: 8

Type: Article

DOI: 10.3390/ANTIOX10081228 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus